MURRAY SNOOK: Open Payments
NPI 1326125097 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,278 in 157 payments from 28 companies in 2025. Trend: 2023 $3,315 · 2024 $4,819 · 2025 $3,278
Food & beverage: $3,278
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $399 |
| Lilly USA, LLC | 19 | $398 |
| AstraZeneca Pharmaceuticals LP | 15 | $395 |
| PFIZER INC. | 10 | $203 |
| Otsuka America Pharmaceutical, Inc. | 14 | $190 |
| Amgen Inc. | 14 | $168 |
| Novo Nordisk Inc | 10 | $166 |
| Corcept Therapeutics | 4 | $159 |
| Kowa Pharmaceuticals America, Inc. | 12 | $149 |
| TMS NeuroHealth Centers Inc. | 4 | $147 |
Products named: JARDIANCE, REXULTI, FARXIGA, AIRSUPRA, Korlym, ZORYVE, TMS NeuroHealth Centers Inc., Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
